So-Young International Inc. American Depository Shares (SY): valor razonable

Tesis ACCE

So-Young International runs China's largest online platform for cosmetic and aesthetic medical procedures, connecting consumers with licensed clinics and surgeons and monetising through advertising, transaction fees and its consumer-facing content and reviews. The structural case rests on the aesthetic medicine market's shift toward online discovery and booking, where So-Young's brand and review base give it a traffic advantage over smaller rivals, and on a gross margin of 46.0% that suggests its marketplace model is pricing reasonably well. Revenue grew 45.6% over the last year, and the stock trades on a forward P/E of 16.3, a sharp contrast with an operating margin of -13.4% and an ROE of -15.0%, so the multiple is only meaningful if the company converts that top-line momentum into operating profit. The near-term question is whether operating losses narrow as revenue scales, which is the single variable a deeper look should test. At a market cap of $235M and no index membership, the name sits in a thin-coverage corner of the market, where a turn in profitability could reprice the stock quickly in either direction. The composite score of 53/100 signals a mixed profile rather than a clear screen pass, so the work ahead is to separate durable growth from growth bought with losses.